IONS - EU approves Biogen treatment for genetic form of ALS
2024-05-30 17:30:28 ET
More on Biogen
- Biogen: Reasons To Be Cheerful After Upbeat Q1 Earnings
- Biogen: Don't Overthink This One
- Biogen's Revenue Dip Meets Cost Cuts In Q1 (Rating Upgrade)
- Biogen inks $1.8B deal to acquire immune drug developer HI-Bio
- Biogen also drops collaboration with Ionis on Angelman syndrome candidate